Dexedrine for ADHD
Weekend ICYMI: October 7 to October 11
In case you missed it, this week we had stories about medication-related disaster preparedness, COVID-19 and cardiovascular risks, legal battles over inflated insulin prices, and more.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
FDA Approves First Weekly Subcutaneous Therapy for Hemophilia B
Marstacimab-hncq is the first non-factor and once-weekly treatment available for patients with hemophilia B and promises to reduce the burden of care.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
FDA Approves Imuldosa, Biosimilar to Stelara
The approval is supported by results from phase 3 multi-regional clinical trials conducted in patients with plaque psoriasis.
Supplement Snapshot: Vitamin D and Respiratory Tract Infections
Recent research on vitamin D supplementation and respiratory tract infections can help guide pharmacists in counseling patients.
